Blocking HCV entry as potential antiviral therapy

Author： Vercauteren Koen   Leroux-Roels Geert   Meuleman Philip  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.6, 2012-06, pp. : 547-561

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral HCV therapy: give drug users a fair go

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 323, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection

By Iacobellis Angelo   Andriulli Angelo  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 1929-1938

Informa Healthcare

Access to resources Recommend Favorite

Antiviral HCV therapy: give drug users a fair go

By  

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors

By Kilby J.M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1157-1170

Informa Healthcare

Access to resources Recommend Favorite

Virus Attachment and Entry Offer Numerous Targets for Antiviral Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 30, 2004-01 ,pp. : 3701-3712

Bentham Science Publishers

Access to resources Recommend Favorite